GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Diagnosed prevalent cases of HER2- breast cancer across 8MM set to reach 4.12 million in 2034, forecasts GlobalData

The burden of five-year diagnosed prevalent cases of HER2-Negative (HER2-) breast cancer is expected to increase at an annual growth rate (AGR) of 1.42% from around 3.61 million in 2024 to 4.12 million in 2034 across the eight major markets (8MM*), forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “HER2-Negative Breast Cancer: […]
Read more

Skoda’s YouTube campaigns spotlight innovation, sustainability, and design excellence, reveals GlobalData

Skoda’s YouTube advertising campaigns from Q2 2025 effectively highlight the brand’s emphasis on innovation, sustainability, and user-centric design to capture the attention of a wide spectrum of consumers. Through EV models like the Enyaq iV and Elroq RS, along with unique collaborations such as the limited-edition Botas shoes, Skoda’s ads combine striking design, advanced features, […]
Read more

Semaglutide emerges as contender in cerebrovascular disease management, says GlobalData

Semaglutide, a GLP-1R agonist also known as Ozempic or Wegovy and initially developed for type 2 diabetes, is emerging as a promising candidate for neurological conditions. The recent clinical findings suggest its potential to improve outcomes in stroke and brain hemorrhage patients, driven by its cardiovascular and anti-inflammatory effects. These developments highlight a significant therapeutic […]
Read more

Barclays and KPMG top M&A financial advisers in automotive sector in H1 2025, reveals GlobalData

Barclays and KPMG were the top mergers and acquisitions (M&A) financial advisers in the automotive sector during the first half (H1) of 2025 by value and volume, respectively according to the latest financial advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database has revealed that Barclays achieved […]
Read more

ICP monitoring devices market grows modestly amid clinical reliance, limited innovation and access gaps, finds GlobalData

Intracranial pressure (ICP) monitoring devices remain essential in managing neurological emergencies, yet the market is maturing slowly amid limited innovation and entrenched clinical preferences. With annual growth at just 2.4%, the sector is shaped more by procedural reliability than technological disruption. Despite their proven value, broader adoption hinges on integrating innovation with clinical workflows and […]
Read more

Tech ESG driven by incrementalism and pragmatism, says GlobalData

Technology sector’s environmental, social and governance (ESG) activities in the second quarter of 2025 have been characterized by incremental progress and pragmatic approaches to changing geopolitical circumstances, reveals Tech ESG Watch, a quarterly newsletter by GlobalData, a leading data and analytics company. Robert Pritchard, Principal Analyst, Enterprise Technology & Services at GlobalData, comments: “In the […]
Read more

US tariffs trigger supply chain reconfiguration and mark end of hyper globalization, says GlobalData

The US tariffs are accelerating the breakdown of hyper-globalization, forcing companies worldwide to rethink their supply chain strategies. As protectionist policies take hold, supply chains are shifting toward localization to mitigate risk and rising costs. Global trade is entering a new era, defined not by efficiency, but by resilience, regionalization, and strategic reconfiguration, says GlobalData, […]
Read more

AP301 phase 3 trial highlights Alebund’s potential to differentiate in HP space, says GlobalData

Alebund Pharmaceuticals announced positive topline phase III results highlighting that the use of AP301 demonstrated a statistically significant and clinically meaningful improvement in serum phosphorus control in dialysis patients with hyperphosphatemia (HP). If approved, AP301 could potentially address two unmet needs in HP management: poor patient adherence and inadequate phosphorus control, says GlobalData, a leading […]
Read more

Zoom Workplace enhancements symbolize both opportunity and hurdles for Zoom, says GlobalData

Zoom’s latest round of enhancements to the Workplace platform raise productivity while sustaining its transformation as a competitor. They also provide Zoom with the challenge of drafting clear market messaging regarding security and positioning, according to GlobalData, a leading data and analytics company. Gregg Willsky, Principal Analyst, Enterprise Technology & Services at GlobalData, comments: “After […]
Read more

A&O Shearman top M&A legal adviser by value in automotive sector in H1 2025, CMS and Kirkland & Ellis lead by volume, reveals GlobalData

A&O Shearman was the top mergers and acquisitions (M&A) legal adviser in the automotive sector during the first half (H1) of 2025 by value, while CMS and Kirkland & Ellis jointly occupied the top position by volume according to the latest legal advisers league table by GlobalData, a leading data and analytics company. An analysis […]
Read more

Supply chain resilience drives global M&A deal value 11% in Q2 2025, reveals GlobalData

Global mergers and acquisitions (M&A) activity rebounded with an 11% increase in total deal value year-over-year (YoY) during the second quarter (Q2) of 2025, driven by falling interest rates, modest economic growth, and a renewed focus on supply chain resilience. Mega-deals reached $438 billion, while $61 billion was tied to supply chain-related transactions, highlighting a […]
Read more
1 51 52 53 54 55 771